Kenmerk
Big lower jaw
Klinische naam: Mandibular prognathia
Abnormal prominence of the chin related to increased length of the mandible.
Samenvatting
- Ook bekend als
- Increased projection of lower jaw, Increased size of lower jaw, Increased size of mandible, Large lower jaw, Prominent chin, Prominent lower jaw, Big mandible, Enlarged mandible, Enlargement of mandible, Hyperplasia of lower jaw, Increased projection of mandible, Large mandible, Lower jaw excess, Lower jaw hyperplasia, Macromandible, Mandible prognathism, Mandibular excess, Mandibular hyperplasia, Mandibular macrognathia, Mandibular prognathism, Prognathia, Prognathism, Prominent jaw, Prominent mandible, Relative mandibular prognathism
Read the genes linked to Big lower jaw, and the rest of your genome, with one test.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken
Mijn Genome Test bestellen226 genen gekoppeld aan Big lower jaw
Veranderingen in deze genen veroorzaken zeldzame aandoeningen waarbij Big lower jaw voorkomt. De meeste mensen met dit kenmerk hebben geen van die aandoeningen, en een gen op deze lijst zegt niets over het eigen genoom van iemand.
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ACANaggrecan | Altijd | In 3 aandoeningen |
| ALG14ALG14 UDP-N-acetylglucosaminyltransferase subunit | Altijd | In 1 aandoening |
| AMOTL1angiomotin like 1 | Altijd | In 1 aandoening |
| APC2APC regulator of Wnt signaling pathway 2 | Altijd | In 1 aandoening |
| ATP6V0A1ATPase H+ transporting V0 subunit a1 | Altijd | In 1 aandoening |
| ATRXATRX chromatin remodeler | Altijd | In 1 aandoening |
| CDH11cadherin 11 | Altijd | In 2 aandoeningen |
| DDX59DEAD-box helicase 59 | Altijd | In 1 aandoening |
| ESAMendothelial cell adhesion molecule | Altijd | In 1 aandoening |
| GNB2G protein subunit beta 2 | Altijd | In 1 aandoening |
| GPC3glypican 3 | Altijd | In 2 aandoeningen |
| HERC1HECT and RLD domain containing E3 ubiquitin protein ligase family member 1 | Altijd | In 2 aandoeningen |
| HS6ST2heparan sulfate 6-O-sulfotransferase 2 | Altijd | In 1 aandoening |
| IL6STinterleukin 6 cytokine family signal transducer | Altijd | In 1 aandoening |
| MED16mediator complex subunit 16 | Altijd | In 1 aandoening |
| MYOD1myogenic differentiation 1 | Altijd | In 1 aandoening |
| NSD1nuclear receptor binding SET domain protein 1 | Altijd | In 1 aandoening |
| PRKG2protein kinase cGMP-dependent 2 | Altijd | In 1 aandoening |
| PTDSS1phosphatidylserine synthase 1 | Altijd | In 2 aandoeningen |
| RNF113Aring finger protein 113A | Altijd | In 1 aandoening |
| RNU2-2RNA, U2 small nuclear 2 | Altijd | In 1 aandoening |
| RPL10ribosomal protein L10 | Altijd | In 3 aandoeningen |
| SLC12A2solute carrier family 12 member 2 | Altijd | In 1 aandoening |
| SLC35A2solute carrier family 35 member A2 | Altijd | In 1 aandoening |
| SLC6A17solute carrier family 6 member 17 | Altijd | In 2 aandoeningen |
| SMAD4SMAD family member 4 | Altijd | In 2 aandoeningen |
| SOSTsclerostin | Altijd | In 3 aandoeningen |
| TPRKBTP53RK binding protein | Altijd | In 1 aandoening |
| UBAP2Lubiquitin associated protein 2 like | Altijd | In 1 aandoening |
| AGAaspartylglucosaminidase | Heel vaak (80–99%) | In 1 aandoening |
| AIPAHR interacting HSP90 co-chaperone | Heel vaak (80–99%) | In 2 aandoeningen |
| GPC4glypican 4 | Heel vaak (80–99%) | In 1 aandoening |
| GPR101G protein-coupled receptor 101 | Heel vaak (80–99%) | In 1 aandoening |
| IL1RAPL1interleukin 1 receptor accessory protein like 1 | Heel vaak (80–99%) | In 1 aandoening |
| LRP5LDL receptor related protein 5 | Heel vaak (80–99%) | In 2 aandoeningen |
| MEN1menin 1 | Heel vaak (80–99%) | In 1 aandoening |
| NHSNHS actin remodeling regulator | Heel vaak (80–99%) | In 1 aandoening |
| PAX3paired box 3 | Heel vaak (80–99%) | In 3 aandoeningen |
| SLC25A24solute carrier family 25 member 24 | Heel vaak (80–99%) | In 2 aandoeningen |
| ACTA1actin alpha 1, skeletal muscle | Vaak (30–79%) | In 1 aandoening |
Toon nog 186 genen
| Gen | Hoe vaak het voorkomt | Aandoeningen |
|---|---|---|
| ADAMTSL1ADAMTS like 1 | Vaak (30–79%) | In 1 aandoening |
| ADAMTSL4ADAMTS like 4 | Vaak (30–79%) | In 1 aandoening |
| AIMP2aminoacyl tRNA synthetase complex interacting multifunctional protein 2 | Vaak (30–79%) | In 1 aandoening |
| ANKHANKH inorganic pyrophosphate transport regulator | Vaak (30–79%) | In 1 aandoening |
| ANTXR1ANTXR cell adhesion molecule 1 | Vaak (30–79%) | In 1 aandoening |
| APCAPC regulator of Wnt signaling pathway | Vaak (30–79%) | In 1 aandoening |
| ASCC3activating signal cointegrator 1 complex subunit 3 | Vaak (30–79%) | In 1 aandoening |
| ATP6V1E1ATPase H+ transporting V1 subunit E1 | Vaak (30–79%) | In 1 aandoening |
| CSNK2Bcasein kinase 2 beta | Vaak (30–79%) | In 1 aandoening |
| DEAF1DEAF1 transcription factor | Vaak (30–79%) | In 1 aandoening |
| DOCK3dedicator of cytokinesis 3 | Vaak (30–79%) | In 1 aandoening |
| EHMT1euchromatic histone lysine methyltransferase 1 | Vaak (30–79%) | In 1 aandoening |
| ERCC1ERCC excision repair 1, endonuclease non-catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| ERCC4ERCC excision repair 4, endonuclease catalytic subunit | Vaak (30–79%) | In 1 aandoening |
| ERCC6ERCC excision repair 6, chromatin remodeling factor | Vaak (30–79%) | In 3 aandoeningen |
| ERCC8ERCC excision repair 8, CSA ubiquitin ligase complex subunit | Vaak (30–79%) | In 3 aandoeningen |
| EXOSC5exosome component 5 | Vaak (30–79%) | In 1 aandoening |
| FBN1fibrillin 1 | Vaak (30–79%) | In 1 aandoening |
| FGFR1fibroblast growth factor receptor 1 | Vaak (30–79%) | In 2 aandoeningen |
| FGFR2fibroblast growth factor receptor 2 | Vaak (30–79%) | In 6 aandoeningen |
| FMR1fragile X messenger ribonucleoprotein 1 | Vaak (30–79%) | In 2 aandoeningen |
| FOXG1forkhead box G1 | Vaak (30–79%) | In 1 aandoening |
| FOXP1forkhead box P1 | Vaak (30–79%) | In 1 aandoening |
| GJA1gap junction protein alpha 1 | Vaak (30–79%) | In 2 aandoeningen |
| IL11RAinterleukin 11 receptor subunit alpha | Vaak (30–79%) | In 1 aandoening |
| KAT5lysine acetyltransferase 5 | Vaak (30–79%) | In 1 aandoening |
| KAT6Alysine acetyltransferase 6A | Vaak (30–79%) | In 1 aandoening |
| KPTNkaptin, actin binding protein | Vaak (30–79%) | In 2 aandoeningen |
| MBD5methyl-CpG binding domain protein 5 | Vaak (30–79%) | In 1 aandoening |
| MED25mediator complex subunit 25 | Vaak (30–79%) | In 1 aandoening |
| MGAT2alpha-1,6-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase | Vaak (30–79%) | In 1 aandoening |
| NFIXnuclear factor I X | Vaak (30–79%) | In 1 aandoening |
| OPHN1oligophrenin 1 | Vaak (30–79%) | In 2 aandoeningen |
| PCGF2polycomb group ring finger 2 | Vaak (30–79%) | In 1 aandoening |
| PDE4Dphosphodiesterase 4D | Vaak (30–79%) | In 3 aandoeningen |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Vaak (30–79%) | In 1 aandoening |
| PMM2phosphomannomutase 2 | Vaak (30–79%) | In 1 aandoening |
| POGZpogo transposable element derived with ZNF domain | Vaak (30–79%) | In 1 aandoening |
| PQBP1polyglutamine binding protein 1 | Vaak (30–79%) | In 3 aandoeningen |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Vaak (30–79%) | In 2 aandoeningen |
| PTENphosphatase and tensin homolog | Vaak (30–79%) | In 1 aandoening |
| RAF1Raf-1 proto-oncogene, serine/threonine kinase | Vaak (30–79%) | In 2 aandoeningen |
| RAI1retinoic acid induced 1 | Vaak (30–79%) | In 2 aandoeningen |
| RMRPRNA component of mitochondrial RNA processing endoribonuclease | Vaak (30–79%) | In 1 aandoening |
| RUNX2RUNX family transcription factor 2 | Vaak (30–79%) | In 1 aandoening |
| RUSC2RUN and SH3 domain containing 2 | Vaak (30–79%) | In 1 aandoening |
| SFRP4secreted frizzled related protein 4 | Vaak (30–79%) | In 2 aandoeningen |
| SH3PXD2BSH3 and PX domains 2B | Vaak (30–79%) | In 1 aandoening |
| STAG2STAG2 cohesin complex component | Vaak (30–79%) | In 1 aandoening |
| STAT3signal transducer and activator of transcription 3 | Vaak (30–79%) | In 1 aandoening |
| STEEP1STING1 ER exit protein 1 | Vaak (30–79%) | In 1 aandoening |
| STT3ASTT3 oligosaccharyltransferase complex catalytic subunit A | Vaak (30–79%) | In 1 aandoening |
| SVILsupervillin | Vaak (30–79%) | In 1 aandoening |
| UPF3BUPF3B regulator of nonsense mediated mRNA decay | Vaak (30–79%) | In 1 aandoening |
| ZEB2zinc finger E-box binding homeobox 2 | Vaak (30–79%) | In 2 aandoeningen |
| ACBD6acyl-CoA binding domain containing 6 | Soms (5–29%) | In 1 aandoening |
| ACTBactin beta | Soms (5–29%) | In 1 aandoening |
| AFF3ALF transcription elongation factor 3 | Soms (5–29%) | In 1 aandoening |
| ATAD3AATPase family AAA domain containing 3A | Soms (5–29%) | In 2 aandoeningen |
| ATP10AATPase phospholipid transporting 10A (putative) | Soms (5–29%) | In 1 aandoening |
| CACNA1Gcalcium voltage-gated channel subunit alpha1 G | Soms (5–29%) | In 1 aandoening |
| CDC42BPBCDC42 binding protein kinase beta | Soms (5–29%) | In 1 aandoening |
| CHD8chromodomain helicase DNA binding protein 8 | Soms (5–29%) | In 1 aandoening |
| CLCN3Cl-/H+ antiporter 3 | Soms (5–29%) | In 1 aandoening |
| CLIC2CLIC family member 2 | Soms (5–29%) | In 1 aandoening |
| CNOT3CCR4-NOT transcription complex subunit 3 | Soms (5–29%) | In 1 aandoening |
| CRELD1CRELD disulfide isomerase 1 | Soms (5–29%) | In 1 aandoening |
| CTCFCCCTC-binding factor | Soms (5–29%) | In 1 aandoening |
| DHX30DExH-box helicase 30 | Soms (5–29%) | In 1 aandoening |
| DLK1delta like non-canonical Notch ligand 1 | Soms (5–29%) | In 1 aandoening |
| DOT1LDOT1 like histone lysine methyltransferase | Soms (5–29%) | In 1 aandoening |
| FAM20CFAM20C golgi associated secretory pathway kinase | Soms (5–29%) | In 1 aandoening |
| FBXO11F-box protein 11 | Soms (5–29%) | In 1 aandoening |
| FBXW11F-box and WD repeat domain containing 11 | Soms (5–29%) | In 1 aandoening |
| GORABgolgin, RAB6 interacting | Soms (5–29%) | In 2 aandoeningen |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Soms (5–29%) | In 1 aandoening |
| GRIA4glutamate ionotropic receptor AMPA type subunit 4 | Soms (5–29%) | In 1 aandoening |
| H3-3BH3.3 histone B | Soms (5–29%) | In 1 aandoening |
| H4C5H4 clustered histone 5 | Soms (5–29%) | In 1 aandoening |
| HNF1BHNF1 homeobox B | Soms (5–29%) | In 1 aandoening |
| HNRNPH1heterogeneous nuclear ribonucleoprotein H1 | Soms (5–29%) | In 1 aandoening |
| INSRinsulin receptor | Soms (5–29%) | In 2 aandoeningen |
| KCTD1potassium channel tetramerization domain containing 1 | Soms (5–29%) | In 1 aandoening |
| KDM5Clysine demethylase 5C | Soms (5–29%) | In 1 aandoening |
| KDM6Blysine demethylase 6B | Soms (5–29%) | In 1 aandoening |
| LTBP3latent transforming growth factor beta binding protein 3 | Soms (5–29%) | In 1 aandoening |
| MAFMAF bZIP transcription factor | Soms (5–29%) | In 1 aandoening |
| MAN2B1mannosidase alpha class 2B member 1 | Soms (5–29%) | In 2 aandoeningen |
| MED13Lmediator complex subunit 13L | Soms (5–29%) | In 1 aandoening |
| MEG3maternally expressed 3 | Soms (5–29%) | In 1 aandoening |
| MESDmesoderm development LRP chaperone | Soms (5–29%) | In 1 aandoening |
| MYH7myosin heavy chain 7 | Soms (5–29%) | In 1 aandoening |
| MYH8myosin heavy chain 8 | Soms (5–29%) | In 1 aandoening |
| NDST1N-deacetylase and N-sulfotransferase 1 | Soms (5–29%) | In 1 aandoening |
| NEXMIFneurite extension and migration factor | Soms (5–29%) | In 1 aandoening |
| NSRP1nuclear speckle splicing regulatory protein 1 | Soms (5–29%) | In 1 aandoening |
| OCA2OCA2 melanosomal transmembrane protein | Soms (5–29%) | In 1 aandoening |
| OCRLOCRL inositol polyphosphate-5-phosphatase | Soms (5–29%) | In 1 aandoening |
| PCDHGC4protocadherin gamma subfamily C, 4 | Soms (5–29%) | In 1 aandoening |
| PGAP2post-GPI attachment to proteins 2 | Soms (5–29%) | In 1 aandoening |
| PGAP3post-GPI attachment to proteins phospholipase 3 | Soms (5–29%) | In 1 aandoening |
| PIGBphosphatidylinositol glycan anchor biosynthesis class B | Soms (5–29%) | In 1 aandoening |
| PIGLphosphatidylinositol glycan anchor biosynthesis class L | Soms (5–29%) | In 1 aandoening |
| PIGOphosphatidylinositol glycan anchor biosynthesis class O | Soms (5–29%) | In 1 aandoening |
| PIGVphosphatidylinositol glycan anchor biosynthesis class V | Soms (5–29%) | In 2 aandoeningen |
| PIGWphosphatidylinositol glycan anchor biosynthesis class W | Soms (5–29%) | In 1 aandoening |
| PIGYphosphatidylinositol glycan anchor biosynthesis class Y | Soms (5–29%) | In 1 aandoening |
| PLAAT3phospholipase A and acyltransferase 3 | Soms (5–29%) | In 1 aandoening |
| PRKACBprotein kinase cAMP-activated catalytic subunit beta | Soms (5–29%) | In 1 aandoening |
| PTCH1patched 1 | Soms (5–29%) | In 2 aandoeningen |
| PTCH2patched 2 | Soms (5–29%) | In 1 aandoening |
| PUF60poly(U) binding splicing factor 60 | Soms (5–29%) | In 1 aandoening |
| PYCR1pyrroline-5-carboxylate reductase 1 | Soms (5–29%) | In 1 aandoening |
| RFX7regulatory factor X7 | Soms (5–29%) | In 1 aandoening |
| RNF125ring finger protein 125 | Soms (5–29%) | In 1 aandoening |
| RTL1retrotransposon Gag like 1 | Soms (5–29%) | In 1 aandoening |
| SELENONselenoprotein N | Soms (5–29%) | In 1 aandoening |
| SLC10A7solute carrier family 10 member 7 | Soms (5–29%) | In 1 aandoening |
| SLC35C1solute carrier family 35 member C1 | Soms (5–29%) | In 1 aandoening |
| SLC4A10solute carrier family 4 member 10 | Soms (5–29%) | In 1 aandoening |
| SLC6A1solute carrier family 6 member 1 | Soms (5–29%) | In 1 aandoening |
| SLC6A11solute carrier family 6 member 11 | Soms (5–29%) | In 1 aandoening |
| SMPD4sphingomyelin phosphodiesterase 4 | Soms (5–29%) | In 1 aandoening |
| SNRPNsmall nuclear ribonucleoprotein polypeptide N | Soms (5–29%) | In 1 aandoening |
| SUFUSUFU negative regulator of hedgehog signaling | Soms (5–29%) | In 1 aandoening |
| SUZ12SUZ12 polycomb repressive complex 2 subunit | Soms (5–29%) | In 1 aandoening |
| TBCKTBC1 domain containing kinase | Soms (5–29%) | In 2 aandoeningen |
| TONSLtonsoku like, DNA repair protein | Soms (5–29%) | In 2 aandoeningen |
| TTNtitin | Soms (5–29%) | In 1 aandoening |
| UBE3Aubiquitin protein ligase E3A | Soms (5–29%) | In 5 aandoeningen |
| WDR62WD repeat domain 62 | Soms (5–29%) | In 1 aandoening |
| WDR83OSWD repeat domain 83 opposite strand | Soms (5–29%) | In 1 aandoening |
| ZFXzinc finger protein X-linked | Soms (5–29%) | In 1 aandoening |
| ZRSR2zinc finger CCCH-type, RNA binding motif and serine/arginine rich 2 | Soms (5–29%) | In 1 aandoening |
| CNTNAP2contactin associated protein 2 | Zelden (1–4%) | In 1 aandoening |
| COL13A1collagen type XIII alpha 1 chain | Zelden (1–4%) | In 1 aandoening |
| COLQcollagen like tail subunit of asymmetric acetylcholinesterase | Zelden (1–4%) | In 1 aandoening |
| DNMT3ADNA methyltransferase 3 alpha | Zelden (1–4%) | In 1 aandoening |
| GJA5gap junction protein alpha 5 | Zelden (1–4%) | In 1 aandoening |
| GJA8gap junction protein alpha 8 | Zelden (1–4%) | In 1 aandoening |
| H3-3AH3.3 histone A | Zelden (1–4%) | In 1 aandoening |
| KIF7kinesin family member 7 | Zelden (1–4%) | In 1 aandoening |
| LAMB2laminin subunit beta 2 | Zelden (1–4%) | In 1 aandoening |
| SMSspermine synthase | Zelden (1–4%) | In 2 aandoeningen |
| AGPAT21-acylglycerol-3-phosphate O-acyltransferase 2 | Niet vastgelegd | In 1 aandoening |
| AP1S2adaptor related protein complex 1 subunit sigma 2 | Niet vastgelegd | In 1 aandoening |
| AP4M1adaptor related protein complex 4 subunit mu 1 | Niet vastgelegd | In 1 aandoening |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Niet vastgelegd | In 1 aandoening |
| CHRNEcholinergic receptor nicotinic epsilon subunit | Niet vastgelegd | In 1 aandoening |
| CLCN4Cl-/H+ antiporter 4 | Niet vastgelegd | In 1 aandoening |
| CUL4Bcullin 4B | Niet vastgelegd | In 1 aandoening |
| CUL7cullin 7 | Niet vastgelegd | In 1 aandoening |
| DYMdymeclin | Niet vastgelegd | In 1 aandoening |
| EZH2enhancer of zeste 2 polycomb repressive complex 2 subunit | Niet vastgelegd | In 1 aandoening |
| FLCNfolliculin | Niet vastgelegd | In 1 aandoening |
| GALNSgalactosamine (N-acetyl)-6-sulfatase | Niet vastgelegd | In 1 aandoening |
| GFPT1glutamine--fructose-6-phosphate transaminase 1 | Niet vastgelegd | In 1 aandoening |
| GLB1galactosidase beta 1 | Niet vastgelegd | In 1 aandoening |
| GNPTABN-acetylglucosamine-1-phosphate transferase subunits alpha and beta | Niet vastgelegd | In 1 aandoening |
| HERC2HECT and RLD domain containing E3 ubiquitin protein ligase 2 | Niet vastgelegd | In 1 aandoening |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Niet vastgelegd | In 1 aandoening |
| IDUAalpha-L-iduronidase | Niet vastgelegd | In 1 aandoening |
| KCNH1potassium voltage-gated channel subfamily H member 1 | Niet vastgelegd | In 1 aandoening |
| KIF11kinesin family member 11 | Niet vastgelegd | In 1 aandoening |
| LRP4LDL receptor related protein 4 | Niet vastgelegd | In 1 aandoening |
| MAGEL2MAGE family member L2 | Niet vastgelegd | In 1 aandoening |
| MSTO1misato mitochondrial distribution and morphology regulator 1 | Niet vastgelegd | In 1 aandoening |
| MUSKmuscle associated receptor tyrosine kinase | Niet vastgelegd | In 1 aandoening |
| MYH3myosin heavy chain 3 | Niet vastgelegd | In 1 aandoening |
| POC1APOC1 centriolar protein A | Niet vastgelegd | In 1 aandoening |
| PTPN11protein tyrosine phosphatase non-receptor type 11 | Niet vastgelegd | In 1 aandoening |
| RECQL4RecQ like helicase 4 | Niet vastgelegd | In 1 aandoening |
| RPS6KA3ribosomal protein S6 kinase A3 | Niet vastgelegd | In 1 aandoening |
| SETD2SET domain containing 2, histone lysine methyltransferase | Niet vastgelegd | In 1 aandoening |
| SLC6A8solute carrier family 6 member 8 | Niet vastgelegd | In 1 aandoening |
| SLC9A6solute carrier family 9 member A6 | Niet vastgelegd | In 1 aandoening |
| SOX18SRY-box transcription factor 18 | Niet vastgelegd | In 1 aandoening |
| SRCAPSnf2 related CREBBP activator protein | Niet vastgelegd | In 1 aandoening |
| TAFAZZINtafazzin, phospholipid-lysophospholipid transacylase | Niet vastgelegd | In 1 aandoening |
| TBC1D7TBC1 domain family member 7 | Niet vastgelegd | In 1 aandoening |
| TGFB1transforming growth factor beta 1 | Niet vastgelegd | In 1 aandoening |
| THUMPD1THUMP domain 1 NAT10 acetyltransferase adaptor | Niet vastgelegd | In 1 aandoening |
| TNFSF11TNF superfamily member 11 | Niet vastgelegd | In 1 aandoening |
| TNNI2troponin I2, fast skeletal type | Niet vastgelegd | In 1 aandoening |
| TWIST2twist family bHLH transcription factor 2 | Niet vastgelegd | In 1 aandoening |
| TXNL4Athioredoxin like 4A | Niet vastgelegd | In 1 aandoening |
Hoe vaak dit voorkomt bij mensen met een van de aandoeningen van het gen, de hoogste frequentie binnen die aandoeningen, zoals de Human Phenotype Ontology dit vastlegt. Deze pagina's beschrijven kenmerken en het onderzoek erachter; het zijn geen diagnose, en over symptomen kunt u het best een arts of genetisch adviseur raadplegen.
Bredere kenmerken
Waar dit vandaan komt
- De Human Phenotype Ontology, release 2026-09-01: het kenmerk, de namen, de definitie en de genen die ermee verbonden zijn. Meer informatie vindt u op hpo.jax.org.
- Gegevensrelease 2026.10.16-c6eea6bf.
Eén test. Een leven lang antwoorden.
Vanaf $ 449Gratis verzending · Resultaten binnen 6–8 weken